+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years +
All Genders
ID06263153

Phase II Study of Futibatinib and Durvalumab Before Bladder Removal Surgery in Patients with Muscle-Invasive Bladder Cancer Ineligible for Cisplatin

Led by Yuanquan Yang · Updated on 2026-10-01

24

Participants Needed

3

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating a combination treatment using futibatinib and durvalumab before bladder removal surgery in patients with muscle-invasive bladder cancer MIBC who cannot receive standard cisplatin-based therapy. This phase II trial focuses on patients with FGFR overexpression and aims to assess the treatments ability to eliminate cancer cells completely, along with its safety and effects on survival and surgery timing. Participants take futibatinib by mouth once daily for 28 days and receive durvalumab intravenously on the first day of each 28-day cycle, repeating this for up to three cycles if no disease progression or unacceptable side effects occur. After treatment, patients undergo radical cystectomy to remove the bladder within 4 to 12 weeks. During the study, imaging tests CT and MRI and blood samples are collected to monitor the disease and treatment effects. Throughout the trial, participants are closely monitored with follow-up visits at 30 days post-surgery and then every three months for two years. Researchers measure the complete pathological response at surgery, adverse events, cancer stage reduction, overall survival, and progression-free survival. The study also explores biomarkers and tumor environment changes before and after treatment to better understand the therapys impact.

CONDITIONS

Brief Title

Futibatinib in Combination With Durvalumab Prior to Cystectomy for the Treatment of Muscle-Invasive Bladder Cancer Patients Who Are Ineligible for Cisplatin-based Therapy

Research Team

T

The Ohio State Comprehensive Cancer Center

R

Rebecca Williams

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here